Bone Markers
Biochemical and Clinical Perspectives
1st Edition
Published on 1. March 2001
Book
Hardback
240 pages
978-1-84184-023-9 (ISBN)
Description
This monograph brings together the proceedings of a workshop held in Geneva, Switzerland in March 2000 under the joint sponsorship of the University of Sheffield and F Hoffmann La Roche Ltd. Chapters by leading scientists present the latest research on biochemical markers of bone remodelling as well as their clinical applications in the management of osteoporosis. The text focuses on four major areas of interest: 1) potential candidates for markers of bone remodelling, 2) sources of biological bone marker variability, 3) use of biochemical markers in monitoring treatment of osteoporosis, and 4) use of biochemical markers in the prediction of bone loss and fractures. The book also includes transcripts of the lively panel discussions from the Geneva workshop.
More details
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
College/higher education
Professional and scholarly
Academic and Postgraduate
Dimensions
Height: 246 mm
Width: 189 mm
Weight
1032 gr
ISBN-13
978-1-84184-023-9 (9781841840239)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Matthias Baumann | Richard Eastell | Nicholas Hoyle
Bone Markers
Biochemical and Clinical Perspectives
E-Book
11/2024
1st Edition
CRC Press
€245.99
Available for download
Matthias Baumann | Richard Eastell | Nicholas Hoyle
Bone Markers
Biochemical and Clinical Perspectives
E-Book
11/2024
1st Edition
CRC Press
€245.99
Available for download
Persons
Matthias Baumann, Richard Eastell; Nicholas Hoyle; Lothar Wieczorek
Content
1. Introduction 2. Potential Candidates for Bone Turnover Markers: N-Telopeptide Cross Links of Type I Collagen 3. C-Telopeptides 4. Pyridinium Crosslinks as Bone Resorption Markers 5. Bone Specific Alkaline Phosphatase 6. Osteocalcin 7. The N- and C-Terminal Propeptides of Human Procollagen Type I (PINP and PICP) Bone Sialoprotein 8. Biochemical Markers of Bone Turnover: 9. Age, Gender, and Race as Sources of Biological Variability 10. Circadian Rhythm Studies of Serum Bone Resorption Markers: Implications for Optimal Sample Timing and Clinical Utility 11. Sources of Biological Bone Marker Variability 12. The Effects of Fracture or Disease on Biochemical Markers of Bone Remodelling 13. Variation in Biochemical Markers of Bone Turnover: Sources, Quantification, Minimisation 14. The Use of Biochemical Markers of Bone Turnover for Monitoring Treatment of Osteoporosis 15. The Use of Biochemical Markers of Bone Turnover to Monitor Response to Therapy: Statistics and Logic 16. Prediction of Response in Bone Mass by Biochemical Markers of Bone Turnover During Anti-Resorptive Therapy for Prevention of Osteoporosis 17. Biochemical Markers of Bone Turnover as Predictors of Bone Loss and Response to Therapy 18. Assessment of Fracture Risk 19. Markers of Bone Turnover, Endogenous Hormones, Rate of Bone Loss and Fracture Risk in the OFELY Study 20. Prediction of Hip Fractures with Markers of Bone Turnover in the EPIDOS Study 21. Which Fractures are Associated with High Bone Resorption in Elderly Women: The Rotterdam Study 22. The Study of Osteoporotic Fractures 23. The Association Between Bone Turnover and Fracture Risk: The Sheffield Osteoporosis Study 24. Panel Discussions